"MUST READ" Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an ABSOLUTE LIFE CHANGER.
Amazing Website >> http://www.immunotechlab.com/
As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB!
Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.
Well here is my take as to WHY you should BUY IMMB....
IMMB currently carries a HV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png
So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!
As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.
So now we have a growing Board with TOP notch Members whom carry HUGE connections.
Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients
Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE...
From the last PR and in the words of MR.BO LINTON (read BOLD)>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug". If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.
Now that you are seeing what I am seeing I will show you the KICKER >>
CURRENT SHARE STRUCTURE
OUTSTANDING SHARES 60,500,000 give or take a handful
FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000
Want More, I have more >>
INSIDERS HOLDINGS 98% of O/S Here is the PROOF >>
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46
So there you have it!
PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM!
Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.
Your Friend Cheeky!
PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!
"MUST READ" Alright $IMMB Investors and Future Investors
Top 10 Most Recent News Articles
Detroit Pushes Forward with Bold I-75 Urban Cap Plans
Detroit's Ambitious Urban Makeover In a move that's as bold as a Motown groove, Detroit is diving headfirst into a massive project to transform the concrete jungle of I-75 into more than just a bustling highway. We're talking about three public green spaces that are set to entirely reshape the landscape and how the city's neighborhoods merge and function. In short, it's...
Continue Reading
Gen Z's Protein Cravings Drive Grocery Innovation
Reser's Response to a Protein-Packed Demand Some days it feels like this younger generation is rewriting the food playbook. Gen Z, they’re prioritizing protein as if it’s the new gold, but they’re not exactly jumping on the typical offerings like shakes or yet another grilled chicken breast. This uptick in protein munchers has pushed Reser’s Fine Foods—known for...
Continue Reading
CMCC Global Pioneers Tokenized Funds in El Salvador
A Bold Move into Tokenization Tokenization: it's the buzzword that's got folks scratching their heads and bankers keeping an extra bottle of aspirin in their desk drawers. CMCC Global is diving headlong into this brave new world, rolling out two tokenized fund-of-funds right under El Salvador's fresh digital asset rules. Now that's gutsy. The Partners in Innovation...
Continue Reading
Grid Hurdles Stalling Industrial Heat's Future Growth
The Grid's the New Ball and Chain Now that we're done fiddling with tech, let's talk grid. The industrial players itching to switch to electric heat have found a new villain: the grid. You'd think with resistance heating, electric boilers, electric arc furnaces, and the whole shebang ready to roll, it’d be a smooth ride. But nope, the bottleneck's the bloodstream...
Continue Reading
Tierra Encantada Expands Into North Carolina Market
Tierra Encantada is making its way down to the Tar Heel State, bringing its Spanish Immersion Early Education® program to the thriving community of Raleigh. Talk about catching the right wave at the right time. With a burgeoning demand for quality early education in fast-growing markets, Tierra Encantada's expansion into North Carolina seems like a no-brainer. Raleigh:...
Continue Reading
AceMyNursingExams Debuts Versatile Nursing Prep Platform
A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...
Continue Reading
Primis Financial's Q3 2026: Strong Showing Amid Headwinds
Primis Financial's Remarkable Quarter Alright, let's talk about Primis Financial Corp. and their Q3 2026 results. Earnings and other financial marks have seen quite the improvement. We're talking profits here that went from $6.8 million in the prior year to $8.7 million this time around. Nothing to sneeze at. Their net income per share climbed up to $0.35 from $0.28,...
Continue Reading
Amynta's Southern States Deal: A Strategic Move?
Digging Into Amynta's Latest Acquisition Alright, pull up a stool because Amynta Group just wrapped up a deal that could stir up the insurance pot a little. They snagged Southern States Underwriters, a specialty managing general underwriter focusing on commercial property and casualty insurance for the agribusiness sector. With this acquisition, Amynta doesn't just...
Continue Reading
Sunlife's Q3 2026 Results: Market Awaits Key Insights
Sunlife Prepares to Unveil Third Quarter Performance Alright, folks, we're spinning the wheel again and betting on Sun Life Financial's (TSX: SLF) third quarter earnings, taking the spotlight on November 4, 2026. Anyone eyeballing this should circle their calendars, tie their shoelaces, and get prepared. Since they're laying out the details after the markets shut, looks...
Continue ReadingSivers Semiconductors Shakes Up Auditors and Incentives
Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...
Continue ReadingTop 5 Most Recently Viewed Articles
MDWerks High Valuation on IP Assets Shows Future Potential
Valuation of MDWerks’ Intellectual Property Recently, MDWerks, Inc. (OTCQB: MDWK), a trailblazer in sustainable technology, unveiled a remarkable valuation of its intellectual property at an estimated $400 million, provided by a reputable financial advisory firm. This assessment, dated May 31, 2024, serves as a significant metric for the management team as they...
Continue Reading
Theravance Biopharma Insights for Investors at Upcoming Conference
Theravance Biopharma Participation at Investment Conference Theravance Biopharma, Inc. (NASDAQ: TBPH) is making headlines as management prepares to showcase their efforts at an upcoming significant investment event. This participation is aimed at engaging with investors and sharing the company’s latest developments and future potentials. CEO Rick Winningham’s Fireside...
Continue Reading
Understanding the Recent Legal Challenges Facing CarMax, Inc.
Overview of CarMax, Inc. CarMax, Inc. (NYSE: KMX) is a well-known name in the automotive retail industry, primarily dealing with used cars. The company has built its reputation on providing customers with a broad selection of vehicles, alongside a transparent sales process and exceptional customer service. However, recent developments have raised several questions...
Continue Reading
Driving Forces Behind Growth in Surface Plasmon Resonance
Understanding the Surface Plasmon Resonance Market Growth The Surface Plasmon Resonance (SPR) market is on an impressive growth trajectory, with projections indicating a rise from an estimated USD 1,107 million to USD 1,720.3 million by 2032. The expected compound annual growth rate (CAGR) during this period is slated to be around 6.5%. This expansion is a direct...
Continue Reading
Recent Amendments to Tritax Big Box REIT Plc Disclosure Forms
Introduction to Disclosure Amendments In the world of finance, transparency and communication are vital components of a company’s relationship with its investors. Recently, significant amendments have been presented in the form of disclosure documents regarding Tritax Big Box REIT Plc, shedding light on important aspects of their operations and shareholder engagements....
Continue Reading